Elena Pedraz-Cuesta

Elena Pedraz-Cuesta is a Senior Research Scientist in Early Development at Novo Nordisk since May 2024, bringing significant expertise from previous roles as a Senior Scientist and Project Manager at Blue Cell Therapeutics from November 2021 to May 2024 and as a Senior Scientist at Orphazyme A/S from March 2020 to October 2021, where tasks included assay development for Parkinson and lysosomal diseases and project management. Prior experience includes a postdoctoral position at the University of Copenhagen focused on interdisciplinary research and project management from May 2016 to January 2020, another postdoctoral role managing cancer-related projects from 2013 to 2014, and various research roles at Københavns Universitet and the University of Barcelona, where Elena pursued a PhD related to nuclear transcription factors and cancer. Elena holds a Chemistry degree with a specialization in Biochemistry from the University of La Laguna and the University of Barcelona, obtained between 2002 and 2007.